Best TWAS P=4.11e-15 · Best GWAS P=8.56e-15 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | INTS12 | 0.06 | 0.06 | enet | 5 | 0.05 | 2.9e-07 | 7.7 | -7.8 | 8.8e-15 | -1.00 | 0.02 | 0.98 | FALSE |
2 | GTEx | Adipose Subcutaneous | GSTCD | 0.08 | 0.07 | lasso | 8 | 0.07 | 2.9e-06 | 5.7 | 7.0 | 2.7e-12 | 0.76 | 0.08 | 0.92 | FALSE |
3 | GTEx | Adrenal Gland | INTS12 | 0.23 | 0.02 | enet | 21 | 0.04 | 1.4e-02 | 2.2 | -6.1 | 1.0e-09 | -0.60 | 0.05 | 0.76 | FALSE |
4 | GTEx | Artery Aorta | INTS12 | 0.13 | 0.14 | lasso | 3 | 0.14 | 6.5e-08 | 6.3 | -6.4 | 1.3e-10 | -0.90 | 0.03 | 0.97 | FALSE |
5 | GTEx | Cells EBV-transformed lymphocytes | GSTCD | 0.16 | 0.07 | lasso | 17 | 0.03 | 4.3e-02 | 6.5 | 6.8 | 9.4e-12 | 0.92 | 0.02 | 0.94 | FALSE |
6 | GTEx | Cells Transformed fibroblasts | INTS12 | 0.15 | 0.16 | lasso | 9 | 0.17 | 9.5e-13 | 6.5 | -7.1 | 1.1e-12 | -0.96 | 0.03 | 0.97 | FALSE |
7 | GTEx | Esophagus Gastroesophageal Junction | PPA2 | 0.29 | 0.15 | lasso | 5 | 0.14 | 8.8e-06 | -5.8 | -5.4 | 6.1e-08 | -0.07 | 0.58 | 0.02 | TRUE |
8 | GTEx | Esophagus Muscularis | INTS12 | 0.12 | 0.10 | lasso | 15 | 0.10 | 1.3e-06 | 7.6 | -7.3 | 3.0e-13 | -0.98 | 0.02 | 0.98 | FALSE |
9 | GTEx | Nerve Tibial | GSTCD | 0.09 | 0.03 | enet | 16 | 0.02 | 1.3e-02 | 6.1 | 6.8 | 1.4e-11 | 0.73 | 0.06 | 0.90 | FALSE |
10 | GTEx | Pituitary | GSTCD | 0.28 | 0.14 | lasso | 5 | 0.09 | 2.8e-03 | 6.3 | 6.3 | 3.9e-10 | 0.87 | 0.03 | 0.92 | FALSE |
11 | GTEx | Skin Sun Exposed Lower leg | GSTCD | 0.08 | 0.02 | lasso | 6 | 0.01 | 3.8e-02 | 6.3 | 7.1 | 1.4e-12 | 0.78 | 0.03 | 0.96 | FALSE |
12 | GTEx | Thyroid | INTS12 | 0.07 | 0.05 | lasso | 7 | 0.03 | 1.2e-03 | 7.6 | -7.7 | 1.9e-14 | -0.99 | 0.02 | 0.97 | FALSE |
13 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | INTS12 | 0.04 | 0.03 | blup | 51 | 0.04 | 3.9e-04 | 6.5 | -7.2 | 7.5e-13 | -0.92 | 0.01 | 0.96 | FALSE |
14 | The Cancer Genome Atlas | Breast Invasive Carcinoma | INTS12 | 0.04 | 0.03 | blup | 49 | 0.04 | 7.1e-08 | 6.3 | -7.5 | 4.5e-14 | -0.93 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | INTS12 | 0.12 | 0.06 | blup | 50 | 0.08 | 1.2e-04 | 7.6 | -7.4 | 1.1e-13 | -0.88 | 0.01 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | INTS12 | 0.03 | 0.02 | blup | 49 | 0.02 | 6.4e-03 | 7.7 | -7.7 | 1.4e-14 | -0.91 | 0.01 | 0.87 | FALSE |
17 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | INTS12 | 0.08 | 0.10 | lasso | 2 | 0.10 | 2.9e-11 | 7.6 | -7.6 | 3.6e-14 | -0.98 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | INTS12 | 0.32 | 0.00 | blup | 49 | 0.06 | 1.8e-04 | 6.3 | -7.2 | 5.3e-13 | -0.73 | 0.01 | 0.80 | FALSE |
19 | The Cancer Genome Atlas | Brain Lower Grade Glioma | GSTCD | 0.07 | 0.05 | lasso | 4 | 0.04 | 6.6e-05 | 7.7 | 7.9 | 4.1e-15 | 0.99 | 0.02 | 0.98 | TRUE |
20 | The Cancer Genome Atlas | Lung Adenocarcinoma | INTS12 | 0.08 | 0.10 | enet | 11 | 0.10 | 9.9e-12 | 7.7 | -7.5 | 7.7e-14 | -0.97 | 0.01 | 0.99 | FALSE |
21 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | INTS12 | 0.03 | 0.01 | blup | 49 | 0.03 | 6.0e-03 | 4.5 | -6.5 | 1.0e-10 | -0.79 | 0.02 | 0.64 | FALSE |
22 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | INTS12 | 0.22 | 0.15 | lasso | 6 | 0.16 | 2.3e-07 | 6.5 | -6.4 | 1.2e-10 | -0.89 | 0.02 | 0.96 | FALSE |
23 | The Cancer Genome Atlas | Prostate Adenocarcinoma | INTS12 | 0.15 | 0.11 | lasso | 3 | 0.17 | 2.1e-17 | 4.1 | -6.2 | 4.1e-10 | -0.78 | 0.05 | 0.95 | FALSE |
24 | The Cancer Genome Atlas | Stomach Adenocarcinoma | GSTCD | 0.04 | 0.06 | lasso | 1 | 0.05 | 9.1e-05 | 7.5 | 7.5 | 6.9e-14 | 0.95 | 0.02 | 0.94 | FALSE |
25 | The Cancer Genome Atlas | Thyroid Carcinoma | INTS12 | 0.11 | 0.09 | blup | 49 | 0.11 | 1.3e-10 | 7.6 | -7.3 | 3.6e-13 | -0.89 | 0.01 | 0.99 | FALSE |